Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mari

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2008
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancerA Santoro, A Comandone, L Rimassa, et al.
Diabetes Research and Clinical Practice|October 1, 1996
Epidemiology and determinants of blood glucose self-monitoring in clinical practiceN Scorpiglione, M el-Shazly, M Abdel-Fattah, et al.
British Journal of Cancer|December 7, 2007
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activationS Cascinu, R Berardi, S Salvagni, et al.
Gynecologic Oncology|December 14, 2012
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)F Cognetti, A Bagnato, N Colombo, et al.
Chemical Communications (Cambridge, England)|June 20, 2015
A doubly responsive probe for the detection of Cys4-tagged proteinsN Kotera, E Dubost, G Milanole, et al.
British Journal of Cancer|August 25, 2011
Expression and functional role of CRIPTO-1 in cutaneous melanomaA De Luca, L Lamura, L Strizzi, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2008
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancerA Santoro, A Comandone, L Rimassa, et al.
Diabetes Research and Clinical Practice|October 1, 1996
Epidemiology and determinants of blood glucose self-monitoring in clinical practiceN Scorpiglione, M el-Shazly, M Abdel-Fattah, et al.
British Journal of Cancer|December 7, 2007
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activationS Cascinu, R Berardi, S Salvagni, et al.
Gynecologic Oncology|December 14, 2012
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)F Cognetti, A Bagnato, N Colombo, et al.
Chemical Communications (Cambridge, England)|June 20, 2015
A doubly responsive probe for the detection of Cys4-tagged proteinsN Kotera, E Dubost, G Milanole, et al.
British Journal of Cancer|August 25, 2011
Expression and functional role of CRIPTO-1 in cutaneous melanomaA De Luca, L Lamura, L Strizzi, et al.
Pageof 6